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Objective: Patients with chronic obstructive pulmonary disease (COPD) present systemic 
inﬂ  ammation. Strenuous resistive breathing induces systemic inﬂ  ammation in healthy subjects. 
We hypothesized that the increased respiratory load that characterizes COPD can contribute to 
systemic inﬂ  ammation in these patients.
Patients and methods: To test this hypothesis, we compared leukocyte numbers and levels 
of circulating cytokines (tumor necrosis factor alpha [TNFα], interleukin-1β [IL-1β], IL-6, IL-8, 
and IL-10), before and 1 hour after maximal incremental inspiratory loading in 13 patients with 
stable COPD (forced expiratory volume in one second [FEV1] 29 ± 2.5% ref) and in 8 healthy 
sedentary subjects (FEV1 98 ± 5% ref).
Results: We found that: (1) at baseline, patients with COPD showed higher leukocyte counts 
and IL-8 levels than controls (p   0.01); and, (2) one hour after maximal inspiratory loading 
these values were unchanged, except for IL-10, which increased in controls (p   0.05) but not 
in patients with COPD.
Conclusions: This study conﬁ  rms the presence of systemic inﬂ  ammation in COPD, shows that 
maximal inspiratory loading does not increase the levels of pro-inﬂ  ammatory cytokines (IL-1β, 
IL-8) in COPD patients or controls, but suggests that the former may be unable to mount an 
appropriate systemic anti-inﬂ  ammatory response to exercise.
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Introduction
Chronic obstructive pulmonary disease (COPD) is characterized by pulmonary 
(Pauwels et al 2001) and systemic inﬂ  ammation (Agusti et al 2001). In healthy subjects, 
whole body exercise results in increased circulating leukocyte counts (Bury et al 1996), 
higher plasma concentration of pro-inﬂ  ammatory cytokines (interleukin-6 [IL-6], inter-
leukin-1β [ IL-1β], tumor necrosis factor alpha [TNF-α]) (Smith et al 2000), oxidative 
stress (Sen 1995), an increased levels of acute phase reactants (C- reactive protein 
[CRP]) and creatin phosphoquinase (Pizza et al 1995). This occurs also after strenuous 
resistive breathing (Vassilakopoulos et al 1999, 2004).
Airway resistance and the work of breathing are typically increased in patients 
with severe COPD, especially during acute exacerbations of the disease (AECOPD) 
(Barbera et al 1997; Ramirez-Sarmiento et al 2002). Systemic inﬂ  ammation is known 
to increase during AECOPD (Malo et al 2002). We hypothesized that the increased 
respiratory load that characterizes COPD, particularly during AECOPD, can contribute 
to systemic inﬂ  ammation in these patients. To test this hypothesis, we designed a 
prospective and interventional study comparing circulating leukocyte counts and 
plasma concentration of IL-1β, IL-6, TNFα, IL-8, and IL-10 in patients with severe 
COPD and healthy controls, before and after a maximal incremental inspiratory loading 
test (Martyn et al 1987).International Journal of COPD 2008:3(1) 150
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Methods
Subjects and ethics
We studied 13 males with very severe COPD (GOLD 
IV) (Pauwels et al 2001) and 8 healthy male volunteers. 
Patients with COPD were consecutively recruited from 
the outpatient clinic of our department. None of them had 
required hospital admission or treatment change during the 
preceding 3 months nor had any other concomitant chronic 
inﬂ  ammatory disease. All patients received long-acting β2 
agonists, inhaled anticholinergics, and inhaled steroids. 
None of them was receiving oral steroids. We also studied 
8 healthy sedentary volunteers who served as controls. All 
participants gave their written consent after being fully 
informed of the purpose, characteristics, and nature of the 
study, which had been approved by the Ethics Review Board 
of our institution.
Design of the study
Patients were studied in two different days. The first 
one, forced spirometry, arterial blood gases and maximal 
inspiratory and expiratory pressures were determined. Then 
three to seven days later, subjects performed a maximal 
inspiratory loading test (MILT). This was always done at 
the same time of the day (4 pm), at least four hours after 
the last meal. Brieﬂ  y, a venous line was inserted into an 
antecubital vein and a baseline venous blood sample was 
obtained in EDTA containing tubes. MILT was then per-
formed until exhaustion (see below) and, 1 hour later, a 
second venous blood sample was obtained. Plasma was 
separated from whole blood immediately after blood sam-
pling by centrifugation at 2000 rpm for 10 min, and stored 
frozen at –80 °C.
Lung function tests
A forced spirometry (GS, Warren E Collins, Braintree, MA, 
US) was obtained in all participants according to international 
guidelines (American Thoracic Society 1995). Spirometric 
reference values were those of a Mediterranean population 
(Roca et al 1986). In patients with COPD, an arterial blood 
sample was obtained by radial artery punction under local 
anaesthesia. This was immediately assayed for PaO2, PaCO2, 
and pH (IL BG3, Izasa, Spain). This was not obtained in 
healthy subjects who all had normal arterial oxyhemoglobin 
saturation by pulse oxymetry (504-US, Criticare systems, 
Waukesha, WI). Maximum inspiratory pressure (MIP) was 
measured according to the standard technique (Morales et al 
1997) using a differential pressure transducer (Sibelemed, 
Barcelona, Spain) whose output was digitized and stored into 
a computer, while the patient was in the sitting position. MIP 
reference values were from caucasian population (Morales 
et al 1997).
Maximal incremental inspiratory load test 
(MILT)
We followed the methodology described by Martyn and 
colleagues (1987). In brief, subjects were asked to breath 
(following a metronome) through a weighted inspiratory 
plunger (with an orifice whose diameter was 2.1 cm) 
connected to a bidirectional valve, while wearing a nose clip. 
Initially, there was no weight load, but this was increased 
every two minutes with 25 g for COPD patients (or 50 g 
for healthy subjects) until subjects could no longer inspire 
(three unsuccessful attempts to open the inspiratory valve). 
The expiratory circuit was connected to an O2 and CO2 
analyzer (GS, Warren E Collins, Braintree, MA, USA) that 
allowed breath-by-breath measurements of volume, ﬂ  ow, 
oxygen consumption (VO2), and carbon dioxide production 
(VCO2).
Inﬂ  ammatory markers
Total and differential leukocyte counts were determined 
automatically in whole blood (Sysmex K-4500, Toa 
Medical Electronics Co Ltd, Kobe, Japan). In plasma, 
the concentration of IL1β, IL-6, TNFα, IL-10, and IL-8 
was determined using a cytokine bead array system (BD 
Biosciences San Diego, CA, USA). This assay system con-
sists of a mixture of six types of beads of uniform size that 
contain different ﬂ  uorescence intensities of a red-emitting 
dye. A different capture antibody (Ab) against each cyto-
kine is covalently coupled to each type of bead. Cytokines 
bound to these Abs are detected by use of Abs labeled with 
phycoerythrin. The ﬂ  uorescence intensity measured with 
phycoerythrin is proportional to the cytokine concentration 
in the sample and is quantiﬁ  ed from a calibration curve. The 
detection limits of these assays were 7.2 pg/mL for IL-1β, 
2.5 pg/mL for IL-6, 3.7 pg/mL for TNF-α, 3.6 pg/mL for 
IL-8, and 3.3 pg/mL for IL-10. All assays were performed 
in duplicated. Intra-assay variation was  10%.
Statistical analysis
Results are shown as mean ± SEM. The Mann-Whitney 
test was used to compare results between the two groups 
of subjects whereas the Wilcoxon test was used to compare 
data before and after MILT. A p value lower than 0.05 was 
considered signiﬁ  cant.International Journal of COPD 2008:3(1) 151
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Results
Table 1 shows the main clinical and functional data of sub-
jects studied. Patients with COPD were older than controls 
and had severe airﬂ  ow obstruction, mild hypoxemia without 
hypercapnia and a moderate reduction of MIP (Table 1). By 
deﬁ  nition, lung function was normal in healthy volunteers.
Table 2 presents the results of MILT. Healthy subjects 
achieved a higher peak load but the rest of variables were 
similar in both groups. Of note, VO2 increased signiﬁ  cantly 
with MILT in both groups, indicating signiﬁ  cant respiratory 
muscle activity.
Figure 1 presents the values of different inﬂ  ammatory 
markers determined in both groups, before and 1 hour after 
MILT. At baseline, leukocyte counts (panel A) were higher 
in patients with COPD (8.3 ± 0.4 × 103/mL) than controls 
(6.2 ± 0.5 × 103/mL, p   0.01); these values were unchanged 
after MILT, so differences persisted (8.5 ± 0.3 × 103/mL and 
6.5 ± 0.5 × 103/mL respectively, p   0.01). IL-8 levels at 
baseline (panel B), were higher in patients with COPD (15.6 ±
3 pg/mL vs 5.9 ± 0.8 pg/mL, p   0.01). MILT did not change 
these values signiﬁ  cantly so differences remained after it 
(13.4 ± 1.8 pg/mL vs 5.5 ± 0.4 pg/mL respectively, p   0.01). 
The concentration of IL-1β (panel C) was not different 
between groups at baseline (38 ± 19 pg/mL vs 25 ± 8 pg/mL) 
nor did it change with MILT (46 ± 26 pg/mL vs 20 ± 2 pg/mL) 
(panel C). IL-6 and TNF-α levels were undetectable in almost 
all subjects. Interestingly, we observed that IL-10 values 
were similar at baseline but increased after exercise only in 
healthy subjects (5.9 ± 0.8 pg/mL) but not in patients with 
COPD (3.6 ± 0.5 pg/mL, p   0.05) (panel D).
Discussion
This study: (1) conﬁ  rms the presence of systemic inﬂ  amma-
tion in patients with severe COPD, as shown by their higher 
leukocyte counts and increased IL-8 plasma levels; (2) does 
not support the hypothesis that a high inspiratory load may 
contribute to systemic inﬂ  ammation in COPD; and, (3) shows 
that, at variance with healthy subjects, patients with COPD 
were unable to mount an appropriate anti-inﬂ  ammatory 
response after MILT (as indicated by their low plasma levels 
of IL-10 after MILT).
It is now well established that systemic inﬂ  ammation 
occurs in patients with COPD (Agusti et al 2001). In this 
study we hypothesized that the increased respiratory load that 
characterizes COPD may contribute to it. This hypothesis was 
based upon the following, previously established, observa-
tions. First, increased airway resistance is a key physiological 
abnormality in COPD (Hogg 2004). Second, leukocytosis, 
increased circulating levels of pro-inﬂ  ammatory cytokines 
(IL-6, IL-8, IL-1β, TNFα) and oxidative stress have been 
reported in response to intense whole body exercise in 
athletes and healthy subjects (Rohde et al 1997; Smith et al 
2000) and have been shown to persist several hours after 
exercise (Ostrowski et al 1999). Third, albeit smaller in abso-
lute values, a similar systemic inﬂ  ammatory response has 
been described in healthy subjects after strenuous resistive 
breathing (at 75% of their MIP) (Anzueto et al 1994; Bury 
et al 1996; Vassilakopoulos et al 1999). Finally, increased 
TNFα levels have been reported in COPD patients after 
moderate-intensity constant-work-rate exercise (Rabinovich 
et al 2003). To our knowledge, however, no previous study 
has investigated the effects of progressive inspiratory loading 
of the respiratory muscles upon systemic inﬂ  ammation in 
patients with COPD.
At variance with our working hypothesis, we were not able 
to show that that MILT exerts a signiﬁ  cant pro-inﬂ  ammatory 
effect in patients with COPD. Several reasons can explain this 
observation. First, the peak inspiratory load achieved by our 
Table 1 Clinical and lung function data
  COPD patients  Healthy subjects
Age (yrs)  63 ± 2** 46  ± 1
BMI (Kg/m2) 24.7  ± 1.1  26.5 ± 0.6
Smoking history (pack-yr)  62 ± 6** 2.5  ± 2
FEV1 (%reference)  29 ± 2.5** 98  ± 5
FEV1/FVC (%)  37 ± 2** 73± 2
PaO2 (mmHg)  70 ± 3.3  NA
PaCO2 (mmHg)  42 ± 2.3  NA
SaO2% 95  ± 3* 97± 0.4
MIP (% reference)  68 ± 6** 96  ± 8
Abbreviations: BMI, body mass index; FEV1, forced expiratory volume in 1 second; 
FVC, forced vital capacity; PaO2, arterial partial pressure of oxygen; PaCO2, arterial 
partial pressure of carbon dioxide; MIP, maximal inspiratory pressure; NA, not 
available.
**p   0.01.
Table 2 Maximal inspiratory loading test (MILT) results
  COPD patients  Healthy subjects
Pmouth peak/MIP(%)  32.5 ± 6.5  29.9 ± 4.2
Peak load (gr)  125.0 ± 22.4** 287.5  ± 29.5
Duration (seconds)  626 ± 148  654 ± 69
VO2 basal, L × min-1  0.25 ± 0.02  0.28 ± 0.01
VO2 max, L × min-1  0.34 ± 0.04† 0.41  ± 0.04†
VCO2 basal, L × min-1  0.22 ± 0.01  0.23 ± 0.01
VCO2 max, L × min-1  0.25 ± 0.03*† 0.34  ± 0.04†
Abbreviations: Pmouth peak, peak mouth pressure, expressed as percentage 
of Maximal inspiratory pressure (MIP); VO2basal, basal oxygen consumption; VO2max, 
maximal oxygen consumption; VCO2basal, basal CO2 consumption; VCO2max, maximal 
CO2 consumption.
*p   0.05, **p   0.01 versus healthy subjects; †p   0.05 versus basal in the same 
group.International Journal of COPD 2008:3(1) 152
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patients averaged only about 30% of their MIP whereas those 
previous studies in healthy subjects reporting increased sys-
temic inﬂ  ammation after inspiratory loading achieved a peak 
inspiratory load of about 75% of their MIP (Vassilakopoulos 
et al 1999, 2002). It is possible, therefore, that a higher inspira-
tory load may have resulted indeed in systemic inﬂ  ammation in 
our patients, as hypothesized. Yet, the severity of their airﬂ  ow 
obstruction precluded them to achieve and sustain these high 
loads. Actually, Koechlin and colleagues (2004) also failed 
to induce systemic inﬂ  ammation in patients with COPD after 
localized quadriceps exercise at 40% of its maximal strength. 
Second, blood samples were obtained 1 hour after MILT. It 
is therefore possible that earlier sampling may have picked 
up higher systemic cytokine concentrations. However, previ-
ous studies investigating whole body exercise found positive 
results within the time framework used in our study (Suzuki 
et al 1999). Finally, it is known that inhaled steroids can reduce 
systemic inﬂ  ammation in COPD (Sin et al 2004). Given that 
all the patients studied here received them, we can not exclude 
that a different result may have been obtained should patients 
not under inhaled steroid therapy had been studied.
In contrast, we found that the anti-inﬂ  ammatory cyto-
kine IL-10 showed a different response to MILT in healthy 
subjects and in patients with COPD (Figure 1, panel D). 
IL-10 is a primary anti-inﬂ  ammatory cytokine that acts 
by inhibiting pro-inﬂ  ammatory cytokine production by 
activated monocytes and macrophages (Fiorentino et al 
1991). Previous studies in healthy subjects have shown 
that plasma IL-10 increases significantly immediately 
after strenuous exercise (Suzuki et al 2000), ﬁ  tting well 
with the period of resolution of the acute inﬂ  ammatory 
response elicited by exercise (Ostrowski et al 1999; Smith 
et al 2000; Vassilakopoulos et al 2002). Also, these studies 
demonstrate that exercise induces a cascade of cytokine and 
the anti-inﬂ  ammatory cytokine suggesting that there is a 
balance between pro-inﬂ  ammatory and anti-inﬂ  ammatory 
cytokines during and/or after exercise. In keeping with these 
observations, we found that IL-10 increased signiﬁ  cantly 
after MILT in healthy subjects (Figure 1, panel D). In con-
trast, patients with COPD failed to do so. This may reﬂ  ect 
a certain inability to restrict the magnitude and/or duration 
of the inﬂ  ammatory response that may occur after exercise. 
Figure 1 Systemic inﬂ  ammatory markers determined in patients with COPD (open squares) and healthy controls (closed squares), before and after maximal incremental 
inspiratory loading. 
*p   0.05, **p   0.01 versus controls.International Journal of COPD 2008:3(1) 153
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It is interesting to note here that IL-10 has also been to be 
found reduced in the sputum of these patients (Takanashi 
et al 1999), which may contribute also to the maintenance 
of airway inﬂ  ammation.
Two potential limitations of our study deserve comment. 
First, because this was a pilot physiological study, we did 
not formally calculated sample size. Instead, we evaluated a 
relatively small number of subjects, similarly to what other 
studies of this nature have done before (Takanashi et al 
1999; Rabinovich et al 2003; Koechlin et al 2004). Second, 
controls were younger than patients. Some studies have sug-
gested that ageing is associated with systemic inﬂ  ammation 
(De Martinis et al 2006). Therefore, we can not exclude an 
independent effect of ageing.
In summary, the present study suggests that patients with 
severe COPD have systemic inﬂ  ammation and shows that 
MILT in these patients fails to elicit a signiﬁ  cant systemic 
inﬂ  ammatory response. Yet, the capacity of these patients 
to mount an adequate anti-inﬂ  ammatory response seems 
jeopardized. Whether this occurs also during other forms of 
respiratory loading (exercise during activities of daily living, 
acute exacerbation of COPD) requires further study.
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